Vise Technologies Inc. Acquires 2,977 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Vise Technologies Inc. lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 44.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,625 shares of the healthcare conglomerate's stock after acquiring an additional 2,977 shares during the period. Vise Technologies Inc.'s holdings in UnitedHealth Group were worth $4,869,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in UNH. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group during the fourth quarter valued at approximately $26,000. Hurley Capital LLC bought a new position in UnitedHealth Group during the fourth quarter valued at approximately $28,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group during the fourth quarter valued at approximately $30,000. Finally, Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group during the fourth quarter valued at approximately $30,000. Institutional investors own 87.86% of the company's stock.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director John H. Noseworthy acquired 300 shares of the stock in a transaction on Wednesday, May 14th. The shares were bought at an average price of $312.16 per share, with a total value of $93,648.00. Following the acquisition, the director now owns 6,063 shares of the company's stock, valued at $1,892,626.08. This trade represents a 5.21% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the stock in a transaction on Wednesday, May 14th. The stock was acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director now directly owns 6,033 shares in the company, valued at $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 109,408 shares of company stock worth $31,607,768 in the last quarter. Company insiders own 0.33% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages recently commented on UNH. Hsbc Global Res lowered UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday. Wolfe Research lowered their price objective on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research note on Tuesday. Erste Group Bank lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, April 30th. TD Cowen lowered UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price objective for the company. in a research note on Monday. Finally, KeyCorp lowered their price objective on UnitedHealth Group from $575.00 to $450.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $441.87.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $296.45 on Friday. The stock's 50-day moving average is $456.57 and its two-hundred day moving average is $506.94. The firm has a market cap of $268.92 billion, a price-to-earnings ratio of 19.13, a PEG ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period in the previous year, the business posted $6.91 EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 2.83%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is presently 35.18%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.